2018 Named Executive Officer Compensation Schedule for Intersect ENT, Inc.
This document outlines the 2018 compensation terms for Intersect ENT, Inc.'s named executive officers, including the President and CEO, CFO, Chief People Officer, COO, and General Counsel. It specifies each executive's annual base salary and the target performance bonus as a percentage of base salary. Actual bonuses are subject to the Compensation Committee's discretion and depend on the company's achievement of financial, commercial, and product pipeline goals.
Exhibit 10.1
2018 Named Executive Officer Compensation
Name | Base Salary (Annual Rate) (1) | Target Performance Bonus (% of Base Salary) (2) | ||||||
Lisa D. Earnhardt | $ | 556,210 | 75 | % | ||||
Jeryl L. Hilleman | $ | 378,000 | 50 | % | ||||
Gwen R. Carscadden | $ | 285,000 | 35 | % | ||||
Richard E. Kaufman | $ | 350,000 | 40 | % | ||||
David A. Lehman | $ | 360,750 | 40 | % |
(1) | Effective January 1, 2018. |
(2) | The actual bonus to be awarded will be at the Compensation Committees discretion based on the Companys performance against goals, including financial, commercial and product pipeline goals, as determined by the Compensation Committee |